fruquintinibregorafenibTAS-102trifluridine-tipiracilbevacizumabmCRCmetastatic colorectal cancer (mCRC)tertiary hospitals
…. The median number of prior treatment lines was four. Prior to fruquintinib, 22 patients had received TAS-102 plus bevacizumab, eight recei…